Decoy Therapeutics Inc. (DCOY) stock
DCOYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.88−0.07 (-7.31%)
Close on Nov 18, 2026Market cap $576.56KP/E –Yield –
Decoy Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Decoy Therapeutics's revenue for the twelve months ending Mar 31, 2023 was $0, down 100.0% year over year. For fiscal 2022 it was $0, down 100.0% from the year before. The highest annual figure on record is $5.23M in fiscal 2020.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $0 | -100.0% |
| FY2021 | Dec 31, 2021 | $1.84M | -64.8% |
| FY2020 | Dec 31, 2020 | $5.23M | +51.0% |
| FY2019 | Dec 31, 2019 | $3.47M | +77.6% |
| FY2018 | Dec 31, 2018 | $1.95M | +53.1% |
| FY2017 | Dec 31, 2017 | $1.27M | +26.1% |
| FY2016 | Dec 31, 2016 | $1.01M | – |
| FY2015 | Dec 31, 2015 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $227.63K | – |
| Q2 FY2025 | Jun 30, 2025 | $0 | – |
| Q1 FY2023 | Mar 31, 2023 | $0 | – |
| Q4 FY2022 | Dec 31, 2022 | $0 | – |
| Q3 FY2022 | Sep 30, 2022 | $0 | – |
| Q2 FY2022 | Jun 30, 2022 | $0 | -100.0% |
| Q1 FY2022 | Mar 31, 2022 | $0 | -100.0% |
| Q4 FY2021 | Dec 31, 2021 | $0 | -100.0% |
| Q3 FY2021 | Sep 30, 2021 | $0 | -100.0% |
| Q2 FY2021 | Jun 30, 2021 | $571.39K | -54.0% |
| Q1 FY2021 | Mar 31, 2021 | $1.27M | +12.0% |
| Q4 FY2020 | Dec 31, 2020 | $1.48M | +42.4% |
| Q3 FY2020 | Sep 30, 2020 | $1.38M | +57.5% |
| Q2 FY2020 | Jun 30, 2020 | $1.24M | +38.8% |
| Q1 FY2020 | Mar 31, 2020 | $1.13M | +72.8% |
| Q4 FY2019 | Dec 31, 2019 | $1.04M | +537.0% |
| Q3 FY2019 | Sep 30, 2019 | $874.95K | +86.5% |
| Q2 FY2019 | Jun 30, 2019 | $895.78K | +264.9% |
| Q1 FY2019 | Mar 31, 2019 | $655.64K | +267.1% |
| Q4 FY2018 | Dec 31, 2018 | $163.07K | -42.3% |
| Q3 FY2018 | Sep 30, 2018 | $469.05K | +13.4% |
| Q2 FY2018 | Jun 30, 2018 | $245.50K | -26.8% |
| Q1 FY2018 | Mar 31, 2018 | $178.58K | -26.4% |
| Q4 FY2017 | Dec 31, 2017 | $282.83K | -5.4% |
| Q3 FY2017 | Sep 30, 2017 | $413.60K | -31.0% |
| Q2 FY2017 | Jun 30, 2017 | $335.52K | – |
| Q1 FY2017 | Mar 31, 2017 | $242.55K | – |
| Q4 FY2016 | Dec 31, 2016 | $298.90K | – |
| Q3 FY2016 | Sep 30, 2016 | $599.07K | – |
See a number that looks wrong?